On the trail of commodities
Contingent capital instruments designed to provide a capital boost before the point of non-viability are laudable but unrealistic, says former RMMG chair Mark White
This white paper looks at the heavy impact of regulation on investment managers, the mitigation of outsourcing risk, inefficiencies in corporate actions processing and the growing importance of collateral management.
More UBS articles
The price of advice
Day of the aggregators
Barclays reverse convertibles dominate the latest US structured product offerings, but there is also diversion into digital payouts and leveraged returns
Battle over Basel
French bank becomes the latest to divulge a revenue impact from a change to overnight indexed swap discounting
UBS snags Groothaert in Luxembourg Financial Group acquisition
Finra and Wall Street dismiss law firm's criticism of UBS case
UBS has beefed up its structured products offering in Europe with the €25 million acquisition of Luxembourg Financial Group, bringing with it chief executive Johan Groothaert
China conduit concerns
Families in focus
This whitepaper reviews the fundamental changes of Liquidity Risk Management under Basel III. It discusses how institutions can meet the regulatory requirements on liquidity risk management by enhancing their liquidity risk analytics, funds transfer pricing methodologies, liquidity stress testing frameworks, and enterprise risk management platforms.